Publications
- MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents?2019 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis2023 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease2023 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor2023 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity2023 | Second Faculty of Medicine
- Emotional prosody recognition is impaired in Alzheimer's disease2022 | Second Faculty of Medicine, Central Library of Charles University
- Effect of a Vegan Diet on Alzheimer's Disease2022 | Second Faculty of Medicine, Central Library of Charles University
- Alzheimer's Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis2022 | Second Faculty of Medicine
- Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS2021 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Evidences for a Role of Gut Microbiota in Pathogenesis and Management of Epilepsy2021 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...